LAVA Therapeutics N.V.
9.00%
2,370,533
1840748
N51517105
Sep 15, 2025
Sep 18, 2025, 07:08 PM
Reporting Persons (6)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P. | Partnership | 9.00% | 2,370,533 | 2,370,533 | 0 |
| Versant Ventures VI GP, L.P. | Partnership | 9.00% | 2,370,533 | 0 | 2,370,533 |
| Versant Ventures VI GP-GP, LLC | Other | 9.00% | 2,370,533 | 0 | 2,370,533 |
| Versant Vantage I, L.P. | Partnership | 2.00% | 532,870 | 532,870 | 0 |
| Versant Vantage I GP, L.P. | Partnership | 2.00% | 532,870 | 0 | 532,870 |
| Versant Vantage I GP-GP, LLC | Other | 2.00% | 532,870 | 0 | 532,870 |
Disclosure Items (3)
Common Shares, par value Euro 0.12 per share
LAVA Therapeutics N.V.
Yalelaan 62, Utrecht, P7, 3584 CM
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
On September 16, 2025, Versant VI sold 307,707 Common Shares at a weighted average price per share of $1.5332 for aggregate proceeds of approximately $471,773.30. On September 16, 2025, Vantage LP sold 192,293 Common Shares at a weighted average price per share of $1.5332 for aggregate proceeds of approximately $294,821.70. On September 17, 2025, Versant VI sold 362,806 Common Shares at a weighted average price per share of $1.4892 for aggregate proceeds of approximately $540,281.58. On September 17, 2025, Vantage LP sold 226,726 Common Shares at a weighted average price per share of $1.4892 for aggregate proceeds of approximately $337,634.66. On September 18, 2025, Versant VI sold 366,111 Common Shares at a weighted average price per share of $1.4418 for aggregate proceeds of approximately $527,858.84. On September 18, 2025, Vantage LP sold 228,791 Common Shares at a weighted average price per share of $1.4418 for aggregate proceeds of approximately $329,870.86.